Carmichael Hill & Associates’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $275K | Hold |
21,000
| – | – | 0.1% | 146 |
|
|
2024
Q2 | $295K | Hold |
21,000
| – | – | 0.12% | 130 |
|
|
2024
Q1 | $355K | Hold |
21,000
| – | – | 0.14% | 112 |
|
|
2023
Q4 | $297K | Hold |
21,000
| – | – | 0.12% | 122 |
|
|
2023
Q3 | $216K | Hold |
21,000
| – | – | 0.1% | 140 |
|
|
2023
Q2 | $346K | Hold |
21,000
| – | – | 0.15% | 104 |
|
|
2023
Q1 | $192K | Hold |
21,000
| – | – | 0.09% | 149 |
|
|
2022
Q4 | $150K | Hold |
21,000
| – | – | 0.08% | 172 |
|
|
2022
Q3 | $105K | Hold |
21,000
| – | – | 0.06% | 190 |
|
|
2022
Q2 | $51K | Buy |
21,000
+12,000
| +133% | +$29.1K | 0.03% | 271 |
|
|
2022
Q1 | $61K | Buy |
9,000
+1,000
| +13% | +$6.78K | 0.03% | 261 |
|
|
2021
Q4 | $65K | Hold |
8,000
| – | – | 0.03% | 249 |
|
|
2021
Q3 | $78K | Hold |
8,000
| – | – | 0.04% | 214 |
|
|
2021
Q2 | $54K | Hold |
8,000
| – | – | 0.03% | 266 |
|
|
2021
Q1 | $72K | Hold |
8,000
| – | – | 0.04% | 222 |
|
|
2020
Q4 | $53K | Buy |
8,000
+2,000
| +33% | +$13.3K | 0.03% | 250 |
|
|
2020
Q3 | $30K | Hold |
6,000
| – | – | 0.02% | 305 |
|
|
2020
Q2 | $48K | Buy |
6,000
+2,000
| +50% | +$16K | 0.04% | 233 |
|
|
2020
Q1 | $32K | Hold |
4,000
| – | – | 0.03% | 272 |
|
|
2019
Q4 | $30K | Buy |
+4,000
| New | +$30K | 0.02% | 296 |
|